Richard Bright (Flinders University); PhD/Enhancing Osseointegration and Preventing Implant-associated Infections Through Biomimetic Nano-modifications (Flinders University); Masters in Applied Science/ Immunology (Charles Sturt University); Bachelor of Science (Honours
Research Fellow, Flinders University, Adelaide, South Australia · Australia
Editorial leadership for International Journal of Global Health ISSN 2693-1176
Research interests
- Pcr
- Cell Culture
- Gel Electrophoresis
- Gene Expression
- Western Blot Analysis
- Cancer Biology
- Flow Cytometry
- Immunohistochemistry
- Molecular Cell Biology
- Immunofluorescence
- Rna Isolation
- Genetics
- Cell Signaling
- Molecular Cloning
- Primary Cell Culture
- Inflammation
- Cancer Research
- Cellular Biology
- Immunocytochemistry
- Meta-Analysis
- Bone
- Stem Cells
- Stem Cell Differentiation
- Systematic Reviews
- Graphpad Prism
- Lipoproteins
- Cartilage
- Dentistry
- Veterinary Medicine
- Toxicology
- Rheumatoid Arthritis
- Animal Models
- Autoantibodies
- Mesenchymal Stem Cell
- Cystic Fibrosis
- Arthritis
- Periodontal Regeneration
- Small Animal Surgery
- Periodontics
- Online Searching
- Primates
- Pluripotent Stem Cells
- Chondrocytes
- Scientific Information
- Stem Cell Therapy
- Chronic Periodontitis
- High Density Lipoproteins (Hdl)
- Pubmed
- Web Of Science
- Medline
- Experimental Arthritis
- Prisma
Biography
Dr. Richard Bright (PhD, BSc) is a Research Fellow at Flinders University, Adelaide, South Australia. His research encompasses diverse areas including immunotherapy for metastatic melanoma, mesenchymal and induced pluripotent stem cells in regenerative medicine and dentistry, and the molecular links between periodontal disease and rheumatoid arthritis, with particular focus on carbamylation, citrullination, and the role of Porphyromonas gingivalis peptidylarginine deiminase in disease pathogenesis. Dr. Bright has published over 35 indexed articles, with his most-cited work, "Gallium Liquid Metal: Nanotoolbox for Antimicrobial Applications" (2023), receiving 125 citations. His systematic reviews and meta-analyses have examined clinical response rates to interleukin-2 therapy, periodontal ligament-derived cells for tissue regeneration, and the influence of periodontal treatment on rheumatoid arthritis outcomes.
Selected publications
- Gallium Liquid Metal: Nanotoolbox for Antimicrobial Applications 2023 cited 125×
- Eradication of Mature Bacterial Biofilms with Concurrent Improvement in Chronic Wound Healing Using Silver Nanoparticle Hydrogel Treatment 2021 cited 54×
- Silver─Gallium Nano‐Amalgamated Particles as a Novel, Biocompatible Solution for Antibacterial Coatings 2023 cited 42×
- Bio-Inspired Nanostructured Ti-6Al-4V Alloy: The Role of Two Alkaline Etchants and the Hydrothermal Processing Duration on Antibacterial Activity 2022 cited 33×
- Key biomarkers in type 2 diabetes patients: A systematic review 2024 cited 28×
- Lipase-Responsive Amphotericin B Loaded PCL Nanoparticles for Antifungal Therapies 2022 cited 17×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJGH for your work?
This journal is guided by Richard Bright (Research Fellow, Flinders University, Adelaide, South Australia) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.